Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2022-04-01
Serie:CJC Open
Länkar:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk